List of scientific publications

Degerman, S et al. Maintained memory in aging is associated with young epigenetic age. 2017. Neurobiol Aging

Djusberg, E et al. High levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein Coding YIPF6 in AR Amplified Prostate Cancer Bone Metastases. 2017. Prostate

Hasni, M S et al. Estrogen receptor beta1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker. 2017. Leuk Lymphoma

Jiang, Y et al. Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin. 2017. Cell Rep

Ling, A et al. TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer. 2017. Oncoimmunology

Mathot, L et al. Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer. 2017. Cancer Res

Melin, B S et al. Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. 2017. Nat Genet

Persson, H et al. Frequent miRNA-convergent fusion gene events in breast cancer. 2017. Nat Commun

Thysell, E et al. A Systems Approach to Prostate Cancer Classification-Letter. 2017. Cancer Res

Uhlen, M et al. A pathology atlas of the human cancer transcriptome. 2017. Science

Ylitalo, E B et al. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response. 2017. Eur Urol

Bergstrom, S H et al. Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness. 2018. Prostate

Borssen, M et al. DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia. 2018. Clin Epigenetics

Brueffer, C et al. Clinical Value of RNA Sequencing-Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network-Breast Initiative. 2018. JCO Precis Oncol

Enroth, S et al. A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer. 2018. Clin Proteomics

Glimelius, B et al. U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden. 2018. Acta Oncol

Hammarstrom, K et al. Stage distribution utilizing magnetic resonance imaging in an unselected population of primary rectal cancers. 2018. Eur J Surg Oncol

Iglesias-Gato, D et al. The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications. 2018. Clin Cancer Res

Nilsson, M P et al. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer. 2018. Breast Cancer Res Treat

Norberg, A et al. Novel variants in Nordic patients referred for genetic testing of telomere-related disorders. 2018. Eur J Hum Genet

Pinheiro, T et al. Reprint of: A chemical screen identifies trifluoperazine as an inhibitor of glioblastoma growth. 2018. Biochem Biophys Res Commun

Ryden, L et al. Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative. 2018. Br J Surg

Tjon-Kon-Fat, L A et al. Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients. 2018. Prostate

Trotta, L et al. Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders. 2018. Orphanet J Rare Dis

Vaniotis, G et al. Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis. 2018. Oncogene

Wikberg, M L et al. Plasma miRNA can detect colorectal cancer, but how early? 2018. Cancer Med

Wu, C et al. RollFISH achieves robust quantification of single-molecule RNA biomarkers in paraffin-embedded tumor tissue samples. 2018. Commun Biol

Adamo, H et al. Prostate cancer induces C/EBPbeta expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome. 2019. Prostate

Amini, R M et al. Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients. 2019. BMC Cancer

Andersson, U et al. The association between longer relative leukocyte telomere length and risk of glioma is independent of the potentially confounding factors allergy, BMI, and smoking. 2019. Cancer Causes Control

Aripaka, K et al. TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer. 2019. EBioMedicine

Barash, U et al. Heparanase promotes glioma progression via enhancing CD24 expression. 2019. Int J Cancer

Berggrund, M et al. Identification of Candidate Plasma Protein Biomarkers for Cervical Cancer Using the Multiplex Proximity Extension Assay. 2019. Mol Cell Proteomics

Biswas, D et al. A clonal expression biomarker associates with lung cancer mortality. 2019. Nat Med

Cancer, M et al. BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells. 2019. Cell Death Dis

Cui, T et al. Invasive cervical tumors with high and low HPV titer represent molecular subgroups with different disease etiology. 2019. Carcinogenesis

Dihge, L et al. Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort. 2019. Clin Cancer Res

Djureinovic, D et al. Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung. 2019. BMC Cancer

Enroth, S et al. High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer. 2019. Commun Biol

Eriksson, M et al. Improved treatment of glioblastoma - changes in survival over two decades at a single regional Centre. 2019. Acta Oncol

Evelonn, E A et al. DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma. 2019. BMC Cancer

Fornvik, D et al. Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment. 2019. Breast Cancer Res Treat

Gustavsson, I et al. Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening. 2019. Virol J

Haider, Z et al. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression. 2019. Cancer Med

Hammarsten, P et al. Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome. 2019. Mod Pathol

Hammarstrom, K et al. Determining the use of preoperative (chemo)radiotherapy in primary rectal cancer according to national and international guidelines. 2019. Radiother Oncol

Hirvonen, E A M et al. Characterization of an X-chromosome-linked telomere biology disorder in females with DKC1 mutation. 2019. Leukemia

Jimenez-Pascual, A et al. ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem Cells. 2019. Cancer Discov

Kolan, S S et al. Growth-inhibition of cell lines derived from B cell lymphomas through antagonism of serotonin receptor signaling. 2019. Sci Rep

Lundgren, C et al. Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer. 2019. Breast Cancer Res Treat

Mezheyeuski, A et al. Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer. 2019. Br J Cancer

Munksgaard Thoren, M et al. Integrin alpha10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival. 2019. Cancers (Basel)

Nilsson, M P et al. High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study. 2019. Breast Cancer Res Treat

Rutegard, M K et al. PET/MRI and PET/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study. 2019. Cancer Imaging

Sjoberg, R L et al. Role of monoamine-oxidase-A-gene variation in the development of glioblastoma in males: a case control study. 2019. J Neurooncol

Sokilde, R et al. Refinement of breast cancer molecular classification by miRNA expression profiles. 2019. BMC Genomics

Staaf, J et al. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. 2019. Nat Med

Strell, C et al. Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ. 2019. J Natl Cancer Inst

Svedlund, J et al. Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancer. 2019. EBioMedicine

Thysell, E et al. Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor. 2019. Mol Oncol

Vallon-Christersson, J et al. Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series. 2019. Sci Rep

Wu, W Y et al. The Genetic Architecture of Gliomagenesis-Genetic Risk Variants Linked to Specific Molecular Subtypes. 2019. Cancers (Basel)

Xie, Y et al. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients. 2019. J Pathol

Abdulla, M et al. Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma. 2020. Eur J Haematol

Abdulla, M et al. Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma. 2020. Am J Hematol

Amini, R M et al. Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome. 2020. Am J Hematol

Andersson-Evelonn, E et al. Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma. 2020. J Transl Med

Berggrund, M et al. Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2. 2020. Virol J.

Brueffer, C et al. The mutational landscape of the SCAN-B real-world primary breast cancer transcriptome. 2020. EMBO Mol Med

Drobin, K et al. Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer. 2020. Cancers (Basel)

Dudka, I et al. Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status. 2020. BMC Cancer

Engvall, M et al. Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics. 2020. BMC Med Genomics

Glimelius, B et al. Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients. 2020. Cancers (Basel)

Glodzik, D et al. Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers. 2020. Nat Commun

Gyllensten, U et al. Preoperative Fasting and General Anaesthesia Alter the Plasma Proteome. 2020. Cancers (Basel).

Haider, Z et al. DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma. 2020. Blood Cancer J

Hammarstrom, K et al. A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer. 2020. Cancers (Basel)

Herrera, M et al. Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer. 2020. Cancers (Basel)

Hikmet, F et al. The protein expression profile of ACE2 in human tissues. 2020. Mol Syst Biol

Jonsson, P et al. Identification of Pre-Diagnostic Metabolic Patterns for Glioma Using Subset Analysis of Matched Repeated Time Points. 2020. Cancers (Basel)

Larsson, C et al. Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer. 2020. NPJ Breast Cancer

Larsson, K et al. Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia. 2020. Growth Factors

Lee, A C et al. OPENchip: an on-chip in situ molecular profiling platform for gene expression analysis and oncogenic mutation detection in single circulating tumour cells. 2020. Lab Chip

Li, X et al. Ex Vivo Organoid Cultures Reveal the Importance of the Tumor Microenvironment for Maintenance of Colorectal Cancer Stem Cells. 2020. Cancers (Basel)

Li, X et al. A Detailed Flow Cytometric Analysis of Immune Activity Profiles in Molecular Subtypes of Colorectal Cancer. 2020. Cancers (Basel)

Lowenmark, T et al. Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer. 2020. Sci Rep

Maturi, N.P. et al. A molecularly distinct subset of glioblastoma requires serum-containing media to establish sustainable bona fide glioblastoma stem cell cultures. 2020. Glia

Menter, T et al. Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy. 2020. Br J Haematol

Miyashita, N et al. ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma. 2020. Cancer Lett

Osterman, E et al. Recurrence Risk after Radical Colorectal Cancer Surgery-Less Than before, But How High Is It?. 2020. Cancers (Basel)

Osterman, E et al. Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort. 2020. Ann Surg Oncol

Quist-Paulsen, P et al. T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol. 2020. Leukemia

Rendo, V et al. Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer. 2020. Sci Rep

Rutegard, M K et al. Rectal cancer: a methodological approach to matching PET/MRI to histopathology. 2020. Cancer Imaging

Sakthikumar, S et al. Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes. 2020. Genome Biol

Voss, G et al. Regulation of cell-cell adhesion in prostate cancer cells by microRNA-96 through upregulation of E-Cadherin and EpCAM. 2020. Carcinogenesis

Ylitalo, E B et al. Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens. 2020. Prostate

Aberg, A M et al. High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer. 2021. Cancers (Basel)

Abu Sabaa, A et al. Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study. 2021. Br J Haematol

Aine, M et al. Molecular analyses of triple-negative breast cancer in the young and elderly. 2021. Breast Cancer Res

Elfving, H et al. Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer. 2021. Lung Cancer

Eltahir, M et al. Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade. 2021. Cancers (Basel)

Ericson Lindquist, K et al. Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines. 2021. J Clin Pathol

Gholiha, A R et al. Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma. 2021. Blood Adv

Gholiha, A R et al. Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue. 2021. Cancers (Basel)

Goldmann, T et al. PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung. 2021. Cancer Immunol Immunother

Gronlund, E et al. Robust treatment planning of dose painting for prostate cancer based on ADC-to-Gleason score mappings - what is the potential to increase the tumor control probability?. 2021. Acta Oncol

Halin Bergstrom, S et al. High-grade tumours promote growth of other less-malignant tumours in the same prostate. 2021. J Pathol

Imam, I et al. Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery? 2021. Radiother Oncol

Li, X et al. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry. 2021. Pathol Res Pract

Mattsson Ulfstedt, J et al. Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma. 2021. Ups J Med Sci

Mezheyeuski, A et al. The Immune Landscape of Colorectal Cancer. 2021. Cancers (Basel)

Micke, P et al. The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types. 2021. EBioMedicine

Morth, C et al. Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma. 2021. Cardiooncology

Osterman, E et al. Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer. 2021. Acta Oncol

Rodrigues, J M et al. Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors. 2021. Br J Haematol

Stratmann, S et al. Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets. 2021. Blood Adv

Tebani, A et al. Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis. 2021. Acta Neuropathol Commun

Ullgren, H et al. Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study. 2021. Acta Oncol

Vajavaara, H et al. Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma. 2021. Haematologica

Ylitalo, E B et al. A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer. 2021. Clin Epigenetics

Zhao, L et al. FACT-seq: profiling histone modifications in formalin-fixed paraffin-embedded samples with low cell numbers. 2021. Nucleic Acids Res

Abdulla, M et al. Outcome in PCNSL patients and its association with PD-L1+ leukocytes in the tumor microenvironment. 2022. Acta Oncol

Abu Sabaa, A et al. Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls. 2022. N Biotechnol

Bjorkblom, B et al., Distinct metabolic hallmarks of WHO classified adult glioma subtypes. 2022. Neuro Oncol

Bratulic, S et al. Noninvasive detection of any-stage cancer using free glycosaminoglycans. 2022. Proc Natl Acad Sci U S A

Chen, L et al. Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays. 2022. Nat Commun

Enblad, M et al. Mucinous rectal cancers: clinical features and prognosis in a population-based cohort. 2022. BJS Open

Enroth, S et al. Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment. 2022. Commun Med (Lond)

Gholiha, A R et al. Checkpoint CD47 expression in classical Hodgkin lymphoma. 2022. Br J Haematol

Governa, V et al. Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization. 2022. Proc Natl Acad Sci U S A

Gyllensten, U et al. Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer. 2022. Cancers (Basel)

Hidman, J et al. Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma. 2022. Acta Haematol

Holmgren, K et al. Preoperative biomarkers related to inflammation may identify high-risk anastomoses in colorectal cancer surgery: explorative study. 2022. BJS Open

Lomakin, A et al. Spatial genomics maps the structure, nature and evolution of cancer clones. 2022. Nature

Lowenmark, T et al. Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer. 2022. Cancer Immunol Immunother

Lowenmark, T et al. Tumour Colonisation of Parvimonas micra Is Associated with Decreased Survival in Colorectal Cancer Patients. 2022. Cancers (Basel)

Lu, X et al. Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival. 2022. Nat Commun

Nie, M et al. The dual role of CD70 in B-cell lymphomagenesis. 2022. Clin Transl Med

Osterlund, E et al. KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer. 2022. Front Oncol

Peglion, F et al. PTEN inhibits AMPK to control collective migration. 2022. Nat Commun

Skaftason, A et al. Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology. 2022. Genes Chromosomes Cancer

Stratmann, S et al. Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression. 2022. Blood Adv

Sundberg, E et al. COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients. 2022. Pediatr Blood Cancer

Thysell, E et al. Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C. 2022. Mol Oncol

Wikstrom, P et al. Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy. 2022. Cancers (Basel)

Zhang, H et al. Profiling chromatin accessibility in formalin-fixed paraffin-embedded samples. 2022. Genome Res

Apollonio, B et al. Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma. 2023. J Clin Invest

Eriksson, A et al. Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia. 2023. Clin Cancer Res

Ginman, B et al. Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2. 2023. Acta Oncol

Ilkhanizadeh, S et al. Live Detection of Neural Progenitors and Glioblastoma Cells by an Oligothiophene Derivative. 2023. ACS Appl Bio Mater

Imam, I et al. Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study. 2023 Cancers (Basel)

Jonsdottir, B et al. Advanced gynecological cancer: Quality of life one year after diagnosis. 2023. PLoS One

Kerdreux, M et al. Porphyromonas gingivalis in Colorectal Cancer and its Association to Patient Prognosis. 2023. J Cancer

Kotol, D et al. Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma. 2023. Cancers (Basel)

Mezheyeuski, A et al. An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers. 2023. EBioMedicine

Nikkarinen, A et al. Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma. 2023. Blood Adv

Pecori, R et al. ADAR1-mediated RNA editing promotes B cell lymphomagenesis. 2023. iScience

Sjöholm, T et al. A whole-body diffusion MRI normal atlas: development, evaluation and initial use. 2023. Cancer Imaging

Spyratou, V et al. Ki67 and prostate specific antigen are prognostic in metastatic hormone naive prostate cancer. 2023. Acta Oncol

Stratmann, S et al. Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children. 2023. Leukemia

Vikman, S et al. Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia. 2023. Ups J Med Sci

Andersson, A et al. Spatial Transcriptome Mapping of the Desmoplastic Growth Pattern of Colorectal Liver Metastases by In Situ Sequencing Reveals a Biologically Relevant Zonation of the Desmoplastic Rim. 2024. Clin Cancer Res

Backman, S et al. The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation. 2024. J Pathol

Cantoni, F et al. On-chip fabrication of tailored 3D hydrogel scaffolds to model cancer cell invasion and interaction with endothelial cells. 2024. APL Bioeng

de Oliveira, KG et al. Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche. 2024. Acta Neuropathol Commun

Edin, S et al. Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy. 2024. Br J Cancer

Forsgren, E et al. Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers. 2024. Br J Haematol

Governa, V et al. Protumoral lipid droplet-loaded macrophages are enriched in human glioblastoma and can be therapeutically targeted. 2024. Sci Transl Med

Grahn, O et al. Mutation of the cyclooxygenase 2 gene promoter and anastomotic leakage in colorectal cancer patients: retrospective cohort study. 2024. BJS Open

Grahn, O et al. Peritoneal infection after colorectal cancer surgery induces substantial alterations in postoperative protein levels: an exploratory study. 2024. Langenbecks Arch Surg

Hammarström, K et al. Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer. 2024. Int J Cancer

Hedlund Lindberg, J et al. Toward ovarian cancer screening with protein biomarkers using dried, self-sampled cervico-vaginal fluid. 2024. iScience

Herre, M et al. AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis. 2024. FASEB Bioadv

Hjortborg, M et al. Systemic inflammatory response in colorectal cancer is associated with tumour mismatch repair and impaired survival. 2024. Sci Rep

Iribarren, C et al. Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis. 2024. J Mol Diagn

Ivansson, E et al. Large-scale proteomics reveals precise biomarkers for detection of ovarian cancer in symptomatic women. 2024. Sci Rep

Jotanovic, J et al. Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors. 2024. Acta Neuropathol

Jotanovic, J et al. Transcriptome Analysis Reveals Distinct Patterns Between the Invasive and Noninvasive Pituitary Neuroendocrine Tumors. 2024. J Endocr Soc

Löding, S et al. Blood based metabolic markers of glioma from pre-diagnosis to surgery. 2024. Sci Rep

Löwenmark, T et al. Parvimonas micra forms a distinct bacterial network with oral pathobionts in colorectal cancer patients. 2024. J Transl Med

Nunes, L et al. Prognostic genome and transcriptome signatures in colorectal cancers. 2024. Nature

Osterlund, E et al. Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts. 2024. Int J Cancer

Ren, W et al. Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. 2024. Leukemia

Rodrigues, J.M et al. MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 - a Nordic Lymphoma Group study. 2024. Haematologica

Sanchez-Castillo, A et al. Sertraline/chloroquine combination therapy to target hypoxic and immunosuppressive serine/glycine synthesis-dependent glioblastomas. 2024. Oncogenesis

Sandberg, E et al. Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma. 2024. Cancers (Basel)

Sköld, C et al. Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer. 2024. Cancer Causes Control

Axelsson, J et al. Characterizing long- and short-survival glioblastoma patients with FLT-PET/MRI and metabolomics. 2025. Neurooncol Adv.

De Sousa-Coelho, AL et al. Drug Repurposing for Targeting Cancer Stem-like Cells in Glioblastoma. 2025. Cancers (Basel).

Doroszko, M et al. The invasion phenotypes of glioblastoma depend on plastic and reprogrammable cell states. 2025. Nat Commun.

Edin, S et al. Differential distribution of immune checkpoints across molecular subtypes of colorectal cancer. 2025. Oncoimmunology

Hamfjord, J et al. Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS-/BRAF-Mutated Metastatic Colorectal Cancer. 2025. Clin Colorectal Cancer

Ju, J et al. Two-Step Transfer Learning Improves Deep Learning-Based Drug Response Prediction in Small Datasets: A Case Study of Glioblastoma. 2025. Bioinform Biol Insights.

Korsavidou Hult, N et al. Inclusion of tumor periphery in radiomics analysis of magnetic resonance images does not improve predictions of preoperative therapy response in patients with rectal cancer. 2025. Abdom Radiol (NY)

Kourtesakis, A et al. Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma. 2025. Oncoimmunology.

Lin, C et al. Molecular classification of microsatellite-instable colorectal cancers reveals distinct predictors of immunotherapy response. 2025. Esmo Gastrointestinal Oncology

Lindgren, M et al. Type IV collagen, carcinoembryonic antigen, osteopontin, and hepatocyte growth factor as biomarkers for liver metastatic colorectal cancer. 2025. Int J Biol Markers

Lundquist, K et al. Metabolomic Insights into Prostate Cancer Treatment and Relapse. 2025. Cancers (Basel).

Marshall, KL et al. Differential bioenergetic profile of human glioblastoma following transplantation of myocyte-derived mitochondria. 2025. PLoS One.

Marshall, KL et al. Enhancing radiation-induced reactive oxygen species generation through mitochondrial transplantation in human glioblastoma. 2025. Sci Rep.

Moskov, M et al. Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancer. 2025. Commun Med (Lond)

Osterlund, E et al. Primary tumour location, molecular alterations, treatments, and outcome in a population-based metastatic colorectal cancer cohort. 2025. BJC Rep

Osterlund, E et al. KRAS and NRAS mutations in Nordic population-based and real-world metastatic colorectal cancer cohorts. 2025. BJC Rep

Ruiz-Moreno, C et al. Charting the Single-Cell and Spatial Landscape of IDH-Wildtype Glioblastoma with Gbmap. 2025. Neuro-Oncology

Sajwan, R et al. A cancer-associated TP53 synonymous mutation induces synthesis of the p53 isoform p53/47. 2025. Br J Cancer

Seligmann, JF et al. Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population. 2025. Ann Oncol

Shi, Z et al. Tissue-resident microbiota impacts colorectal cancer progression and prognosis. 2025. Nat Commun

Skarkova, A et al. Microtubule-associated NAV3 regulates invasive phenotypes in glioblastoma cells. 2025. Brain Pathol.

Spyrou, A et al. Heparan sulfate N-deacetylase/N-sulfotransferase-1 regulates glioblastoma cell migration and invasion.2025. Matrix Biol

Tarai, S et al. Whole-body tumor segmentation from FDG-PET/CT: Leveraging a segmentation prior from tissue-wise projections. 2025. Heliyon

Tetzlaff, SK et al. Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing. 2025. Cell

Ulfstedt, JM et al. Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma. 2025. Cardiooncology

Wicher, G et al. Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression. Neurooncol Adv.

Yadav, RP et al. scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samples. 2025. Nat Commun

Yu, H et al. Spatial TCR clonality and clonal expansion in the in situ microenvironment of non-small cell lung cancer. 2025. J Immunother Cancer

Yuan, M et al. The Human Pathology Atlas for deciphering the prognostic features of human cancers. 2025. EBioMedicine

Ekstrom, J et al. Biomarker discovery study design consistent with the receiver-operator characteristic. 2026. Comput Methods Programs Biomed

Iniguez-Munoz, S et al. Non-coding somatic single-nucleotide variations affecting glioblastoma-specific enhancer elements regulate tumor-promoting gene networks. 2026. Genes Dis